NeutriSci International Inc (NU) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.006x

Based on the latest financial reports, NeutriSci International Inc (NU) has a cash flow conversion efficiency ratio of 0.006x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-5.90K ≈ $-4.27K USD) by net assets (CA$-914.77K ≈ $-661.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NeutriSci International Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

NeutriSci International Inc - Cash Flow Conversion Efficiency Trend (2001–2022)

This chart illustrates how NeutriSci International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NeutriSci International Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NeutriSci International Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Intercede Group LSE:IGP	0.071x
Urbanimmersive Inc V:UI	-0.002x
Lake Winn Resources Corp V:LWR	0.048x
Pacific Imperial Mines Inc V:PPM	0.021x
GenixPharmaceucticals Corporation V:GENX	0.021x
Ristia Bintang Mahkotasejati JK:RBMS	0.003x
Nicolas Miguet et Associes SA PA:MLNMA	N/A
Greencastle Resources Ltd. V:VGN	-0.014x

Annual Cash Flow Conversion Efficiency for NeutriSci International Inc (2001–2022)

The table below shows the annual cash flow conversion efficiency of NeutriSci International Inc from 2001 to 2022. For the full company profile with market capitalisation and key ratios, see NeutriSci International Inc (NU) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	CA$-616.97K ≈ $-446.31K	CA$-166.09K ≈ $-120.15K	0.269x	-98.77%
2021-12-31	CA$-47.60K ≈ $-34.43K	CA$-1.04 Million ≈ $-752.92K	21.866x	+29.71%
2020-12-31	CA$-90.24K ≈ $-65.28K	CA$-1.52 Million ≈ $-1.10 Million	16.857x	+112.24%
2019-12-31	CA$-156.24K ≈ $-113.02K	CA$-1.24 Million ≈ $-897.66K	7.943x	+207.09%
2018-12-31	CA$275.79K ≈ $199.50K	CA$-2.05 Million ≈ $-1.48 Million	-7.417x	+35.68%
2017-12-31	CA$131.39K ≈ $95.04K	CA$-1.51 Million ≈ $-1.10 Million	-11.530x	-239.39%
2016-12-31	CA$664.22K ≈ $480.49K	CA$-2.26 Million ≈ $-1.63 Million	-3.397x	-16.92%
2015-12-31	CA$726.98K ≈ $525.89K	CA$-2.11 Million ≈ $-1.53 Million	-2.906x	-90.58%
2014-12-31	CA$928.71K ≈ $671.82K	CA$-1.42 Million ≈ $-1.02 Million	-1.525x	-270.31%
2014-09-30	CA$2.66 Million ≈ $1.92 Million	CA$-1.10 Million ≈ $-792.22K	-0.412x	-125.16%
2012-12-31	CA$-705.48K ≈ $-510.34K	CA$-1.15 Million ≈ $-835.27K	1.637x	+1042.03%
2011-12-31	CA$-9.12 Million ≈ $-6.60 Million	CA$-1.31 Million ≈ $-945.19K	0.143x	-24.73%
2010-12-31	CA$-6.64 Million ≈ $-4.80 Million	CA$-1.26 Million ≈ $-914.10K	0.190x	-26.84%
2009-12-31	CA$-4.53 Million ≈ $-3.28 Million	CA$-1.18 Million ≈ $-853.79K	0.260x	-58.59%
2008-12-31	CA$-2.79 Million ≈ $-2.02 Million	CA$-1.75 Million ≈ $-1.27 Million	0.629x	-81.79%
2007-12-31	CA$-866.86K ≈ $-627.07K	CA$-2.99 Million ≈ $-2.16 Million	3.451x	-89.81%
2006-12-31	CA$-59.05K ≈ $-42.71K	CA$-2.00 Million ≈ $-1.45 Million	33.870x	+987.40%
2005-12-31	CA$-487.78K ≈ $-352.85K	CA$-1.52 Million ≈ $-1.10 Million	3.115x	-54.65%
2004-12-31	CA$-250.32K ≈ $-181.08K	CA$-1.72 Million ≈ $-1.24 Million	6.868x	+934.22%
2003-12-31	CA$1.06 Million ≈ $769.61K	CA$-875.87K ≈ $-633.59K	-0.823x	+35.27%
2002-12-31	CA$137.29K ≈ $99.32K	CA$-174.62K ≈ $-126.32K	-1.272x	-4043.61%
2001-12-31	CA$337.55K ≈ $244.18K	CA$-10.36K ≈ $-7.49K	-0.031x	--

About NeutriSci International Inc

V:NU Canada Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

CA$2.07 Billion CAD

Market Cap Rank

#30581 Global

#1604 in Canada

Share Price

CA$11.62

Change (1 day)

-2.19%

52-Week Range

CA$11.60 - CA$18.76

All Time High

CA$18.76